Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-jB in prostate cancer cells

Molecular Biology Reports

Volumn 37, Issue 4, 2010, Pages 1849-1855

  Di, Jin Ming ^a   Pang, Jun ^a   Sun, Qi Peng ^a   Zhang, Yan ^a   Fang, You Qiang ^a   Liu, Xiao Pen ^a   Zhou, Jian Hua ^a   Ruan, Xing Xing ^a   Gao, Xin ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

CpG oligonucleotides; Cyclooxygenase 2; NF jB; Prostate cancer; Toll like receptor 9

Indexed keywords

BACTERIAL DNA; CHLOROQUINE; CPG OLIGODEOXYNUCLEOTIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 9; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; MESSENGER RNA; OLIGODEOXYRIBONUCLEOTIDE; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; ENZYME REGULATION; METASTASIS; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; CELL NUCLEUS; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PROSTATE TUMOR; PROTEIN TRANSPORT; TIME; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS);

CELL LINE, TUMOR; CELL NUCLEUS; CHLOROQUINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RNA, MESSENGER; TIME FACTORS; TOLL-LIKE RECEPTOR 9; UP-REGULATION;

EID: 77953149707     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9620-5     Document Type: Article

References (36)

1. Vaidya SA, Cheng G (2003) Toll-like receptors and innate antiviral responses. Curr Opin Immunol 15:402-407. doi:10.1016/ S0952-7915(03)00070-0 (Pubitemid 36930076)
2. Akira S, Hemmi H (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85:85-95. doi: 10.1016/S0165-2478(02)00228- 6 (Pubitemid 36071561)
3. Wagner H (2004) The immunobiology of the TLR9 subfamily. Trends Immunol 25:381-386. doi:10.1016/j.it.2004.04.011 (Pubitemid 38780955)
4. Chen R, Alvero AB, Silasi DA et al (2008) Cancers take their Toll-the function and regulation of Toll-like receptors in cancer cells. Oncogene 27:225-233. doi:10.1038/sj.onc.1210907
5. Huang B, Zhao J, Unkeless JC et al (2008) TLR signaling by tumor and immune cells: A double-edged sword. Oncogene 27:218-224. doi:10.1038/sj.onc. 1210904
6. Salaun B, Coste I, Rissoan MC et al (2006) TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176:4894-4901
7. Kelly MG, Alvero AB, Chen R et al (2006) TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 66:3859-3868. doi:10.1158/0008-5472. CAN-05-3948
8. Huang B, Zhao J, Li H et al (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65:5009-5014. doi:10.1158/0008-5472.CAN-05-0784 (Pubitemid 40827306)
9. Merrell MA, Ilvesaro JM, Lehtonen N et al (2006) Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4:437-447. doi:10.1158/1541-7786.MCR-06-0007 (Pubitemid 44197039)
10. Andaloussi AE, Sonabend AM, Han Y et al (2006) Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors. Glia 54:526-535. doi:10.1002/glia.20401 (Pubitemid 44449333)
11. Droemann D, Albrecht D, Gerdes J et al (2005) Human Lung cancer cells express functionally active Toll-like receptor 9. Respir Res 6:1. doi:10.1186/1465-9921-6-1 (Pubitemid 41357885)
12. Schmausser B, Andulis M, Endrich S et al (2005) Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cell: An implication for interaction with helicobacter pylori. Int J Med Microbiol 295:179-185. doi:10.1016/j.ijmm.2005. 02.009 (Pubitemid 40776102)
13. Kundu SD, Lee C, Billips BK et al (2008) The toll-like receptor pathway: A novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 68:223-229. doi:10.1002/ pros.20710 (Pubitemid 351186234)
14. Ilvesaro JM, Merrell MA, Swain TM et al (2007) Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 67:774-781. doi:10.1002/pros.20562 (Pubitemid 46709446)
15. Jain S, Chakraborty G, Raja R et al (2008) Prostaglandin E2 regulates tumorangiogenesis in prostate cancer. Cancer Res 68:7750-7759. doi:10.1158/0008-5472.CAN-07-6689
16. Attiga FA, Fernandez PM, Weeraratna AT et al (2000) Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 60:4629-4637
17. Nithipatikom K, Isbell MA, Lindholm PF et al (2002) Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis 19:593-601. doi:10.1023/A:1020915914376 (Pubitemid 35454569)
18. Pan MR, Hou MF, Chang HC et al (2008) Cyclooxygenase-2 upregulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells. J Biol Chem 283:11155-11163. doi:10.1074/jbc.M710038200
19. Gee J, Lee IL, Grossman HB et al (2008) Forced COX-2 expression induces PGE(2) and invasion in immortalized urothelial cells. Urol Oncol 26:641-645. doi:10.1016/j.urolonc. 2007.05.015
20. Sansone P, Piazzi G, Paterini P, et al (2008) Cyclooxygenase-2/ Carbonic anhydrase-IX up-regulation promotes invasive potential and hypoxia survival in colorectal cancer cells. J Cell Mol Med. doi:10.1111/j.1582-4934.2008.00580.x
21. Lee EJ, Choi EM, Kim SR et al (2007) Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells. Exp Mol Med 39:469-476
22. N'Guessan PD, Hippenstiel S, Etouem MO et al (2006) Streptococcus pneumoniae induced p38 MAPK- and NF-kappaBdependent COX-2 expression in human lung epithelium. Am J Physiol Lung Cell Mol Physiol 290:L1131-L1138. doi:10.1152/ ajplung.00383.2005 (Pubitemid 43830857)
23. Ikezoe T, Yang Y, Saitoh T et al (2006) PC-SPES down-regulates COX-2 via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells. Int J Oncol 29:453-461
24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. doi:10.1006/meth. 2001.1262 (Pubitemid 34164012)
25. Bernard MP, Phipps RP (2007) CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin Immunol 125:138-148. doi:10.1016/j.clim.2007.07.006 (Pubitemid 47562898)
26. Song PI, Park Y-M, Abraham T et al (2002) Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 119:424-432. doi:10.1046/j.1523-1747.2002.01847.x (Pubitemid 35001953)
27. Wu ZH, Miyamoto S (2007) Many faces of NF-kappaB signaling induced by genotoxic stress. J Mol Med 85:1187-1202. doi: 10.1007/s00109-007-0227-9 (Pubitemid 47622222)
28. Cuzzocrea S, Chatterjee PK, Mazzon E et al (2002) Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 135:496-510. doi:10.1038/sj.bjp. 0704463
29. Nurmi A, Vartiainen N, Pihlaja R et al (2004) Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J Neurochem 91:755-765. doi:10.1111/ j.1471-4159.2004.02756.x (Pubitemid 39431168)
30. He W, Liu Q, Wang L et al (2007) TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44:2850-2859. doi:10.1016/j.molimm.2007.01.022 (Pubitemid 46412506)
31. Suzuki R, Yamamoto M, Saka H et al (2009) A phase II study of carboplatin and paclitacel with meloxicam. Lung Cancer 63:72-76. doi:10.1016/j.lungcan. 2008.04.002
32. Mustafa A, Kruger WD (2008) Suppression of tumor formation by a cyclooxygenase-2 inhibitor and a peroxisome proliferatoractivated receptor gamma agonist in an in vivo mouse model of spontaneous breast cancer. Clin Cancer Res 14:4935-4942. doi: 10.1158/1078-0432.CCR-08-0958
33. Naugler WE, Karin M (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18:19-26. doi: 10.1016/j.gde.2008.01.020 (Pubitemid 351694451)
34. Zha S, Yegnasubramanian V, Nelson WG et al (2004) Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215:1-20. doi:10.1016/j.canlet. 2004.06.014 (Pubitemid 39221453)
35. Matsumoto M, Funami K, Tanabe M et al (2003) Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 171:3154-3162
36. Heil F, Ahmad-Nejad P, Hemmi H et al (2003) The toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 33:2987-2997. doi:10.1002/eji.200324238 (Pubitemid 37428331)